Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer

Table 1 Relationship between the CMTM6 and PD-L1 expression and clinical parameter

Variables	CMTM6 expression		P value	PD-L1 expression		P value
Variables	High (n = 145)	Low (n = 40)		High (n = 140)	Low (n = 45)
Age			0.750			0.637
< 60	72	21		69	24
≥ 60	73	19		71	21
Sex
Male	102	24	0.214	93	33	0.387
Female	43	16		47	12
Size
< 5 (cm)	51	10	0.226	45	16	0.672
≥ 5 (cm)	94	30		95	29
Differentiation
Well	12	3	0.748	10	5	0.468
Moderate	25	9		28	6
Poor	108	28		102	34
Tumor location
Upper	18	6	0.670	15	9	0.251
Middle	19	7		21	5
Lower	108	27		104	31
Borrmann type
III	110	33	< 0.001	111	32	< 0.001
IV	35	7		30	12
Invasive depth
T1	1	1	0.359	2	0	0.645
T2	24	9		25	8
T3	17	7		16	8
T4	103	23		96	30
lymph node metastasis
N0	27	16	0.005	25	18	0.002
N1-N3	118	24		115	27
Peritoneal recurrence (M)
M0	119	38	0.043	113	42	0.007
M1	26	2		27	1
Stage (TNM)
I	10	8	0.035	9	9	0.038
II	20	4		19	5
III	105	27		102	29
IV	10	1		10	1
PD-L1 expression
Low	27	18	< 0.001
High	118	22

CMTM6 CKLF Like MARVEL Transmembrane Domain Containing 6, PD-L1 Programmed death ligand-1

ISSN: 1475-2867